Leonteq Securities’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
SL
Leonteq Securities's CGEM Position: Q3 2026 in Review
Leonteq Securities reduced its Cullinan Therapeutics (CGEM) stake by 50% in Q3 2026, selling an estimated $287K and leaving 15,000 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #476.
Leonteq Securities first reported a position in CGEM in Q1 2022 and has held it in 6 quarters since. The position peaked at $546K in Q2 2026. 180 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Leonteq Securities held 15,000 shares of Cullinan Therapeutics worth $230K as of Q3 2026.
- Leonteq Securities sold 15,000 Cullinan Therapeutics shares in Q3 2026, an estimated $287K.
- Cullinan Therapeutics made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #476 holding.
- Leonteq Securities first reported a position in Cullinan Therapeutics in Q1 2022 and has held it in 6 quarters since.
- Leonteq Securities's Cullinan Therapeutics position peaked at $546K in Q2 2026.
- 180 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.